Navigation Links
Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
Date:4/22/2008

p> interferon potentiates the activity of combination therapy with

nitazoxanide plus peginterferon. The STEALTH C-1(2) trial used 12

weeks of lead-in therapy with nitazoxanide alone. This clinical study

was designed to evaluate the effect of reducing the lead-in phase from

12 weeks to 4 weeks.

In this Phase II study, 44 patients (40 with HCV genotype 4; 3 with HCV

genotype 1; and 1 with HCV genotype 2) received 4 weeks of nitazoxanide

500 mg twice daily followed by Pegasys(R) (peginterferon alfa-2a) and

nitazoxanide for 36 weeks. Romark's STEALTH C-1 trial (see description

above) was used as an historical control, where randomized patients

were treated for 12 weeks with nitazoxanide before adding SOC treatment.

Analysis of data was by intention to treat.

Thirty-five of 44 patients (80%) treated with a 4-week lead-in phase of

nitazoxanide followed by the addition of peginterferon for 36 weeks

experienced a SVR 12 weeks after the end of treatment (SVR12) compared

to 50% in the SOC historical control group (P = 0.004), 61% in patients

receiving a 12-week lead-in with nitazoxanide followed by 36 weeks of

nitazoxanide plus peginterferon, and 79% in patients receiving a 12-

week lead-in with nitazoxanide followed by 36 weeks of nitazoxanide

plus SOC.

Of the 44 patients in the study, 78% (n=40) of patients with HCV

genotype 4, 100% (n=3) of patients with HCV genotype 1, and 100% (n=1)

of HCV genotype 2, had undetectable virus at 12 weeks following end of

treatment.

Adverse events reported for these 44 patients were similar to those

reported in the STEALTH C-1 trial. Patients treated with nitazoxanide

experienced no more side effects than patients who received the SOC

therapy. Only one of the 44 patients discontinued therapy
'/>"/>

SOURCE Romark Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. Romark Laboratories Raises $18 Million in Institutional Financing
3. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 In response to ... Association of Sierra Leone , Direct Relief ... for the treatment of local health workers who ... a new dedicated Ebola care center was constructed for foreign ... facility is not available for local Sierra Leonean health workers. ...
(Date:12/22/2014)... NxStage Medical, Inc. (NASDAQ: NXTM ... announced today that the U.S. Food and Drug ... perform hemodialysis overnight while the patient is at ... System One is the first and only hemodialysis ... Home nocturnal hemodialysis is an ...
(Date:12/22/2014)... Research and Markets ( http://www.researchandmarkets.com/research/hmlfbq/investment ... "Investment Analysis of the US Medical Device Sector ... http://photos.prnewswire.com/prnh/20130307/600769 This ... sector identifies the key trends and rationale for ... mergers and acquisitions. The study will ...
Breaking Medicine Technology:First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3Investment Analysis of the US Medical Device Sector 2
... new approach to research, along with public policies that ... diseases with potentially devastating personal and financial consequences, such ... Ph.D., chairman, president and CEO of Eli Lilly and ... Thursday in London during a keynote address at The ...
... Mass., Feb. 9, 2011 New England Biolabs ... Journal of Visualized Experiments (JoVE) for the EpiMark™ ... suite of new and validated products designed to ... protocol describes a 3-step, PCR-based assay to identify ...
Cached Medicine Technology:Lilly CEO Says Industry, Public Policy Must Pave Way For Innovation 2Lilly CEO Says Industry, Public Policy Must Pave Way For Innovation 3New England Biolabs Releases JoVE Video Protocol Highlighting Assay to Quantitate 5-hmC in Epigenome 2
(Date:12/25/2014)... The click strand woven bamboo flooring ... the business announces a click strand woven bamboo ... 2015. , Click strand woven bamboo flooring replicates ... well-known brand in the bamboo industry. It promises ... bamboo flooring supplier. , “We are happy to ...
(Date:12/25/2014)... iFitDress.com, the popular online supplier of wedding dresses and special ... black one-shoulder cocktail dresses . In addition, all these ... discounted prices, up to 70% off. , The ... only. You know, we have thousands of frequent callers in ... items can visit our website for more details. The current ...
(Date:12/25/2014)... 2014 Helen Harris’ RP (Retinitis Pigmentosa) ... California after an 8 year battle with breast cancer. ... evening in her home in Woodland Hills California after ... , As the founder and volunteer ... pioneered and championed many of today's greatest breakthroughs in ...
(Date:12/25/2014)... News) -- Overeating is common during the holidays, but there ... expert says. "Don,t arrive at a party hungry. It ... you,ll be attending a party, but deprivation leads to hunger, ... Northern Westchester Hospital in Mount Kisco, N.Y., said in a ... the day and even to have a snack before attending ...
(Date:12/25/2014)... 25, 2014 “ SmileStix ” was featured ... the latest and coolest mobile applications on the iOS, Android, ... host of NewsWatch, conducted the app review and shared with ... personal stickers. , The old saying goes, “A picture says ... words that can describe a single image, because each picture ...
Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... publisher of open access journals, is pleased to ... (JCMR) is moving to BioMed Centrals open access ... & Francis. The move from a subscription publisher ... Cardiovascular Magnetic Resonance (SCMR) members and JCMR authors ...
... OCALA, Fla., Dec. 12 Franck,s Compounding Lab ... Pharmacy Services in,Woodruff, Wisconsin. Island Pharmacy owners, Randy ... other personal interests. Selling their,pharmacy to Franck,s Compounding ... ensure the continuance of high quality prescriptions and ...
... and Babies "R" Us to help prepare local moms for the ... ... Dec. 12 With a traditional theme of,pink and blue, local ... Blue Shield hosts a community-wide baby shower today,for local moms-to-be at ...
... found fat mice had harder time fighting gum disease ... people find it harder to fight infections, and a ... new study from Boston University researchers. , In experiments ... , obese mice had less ability to battle gum ...
... antibody,engineering company developing novel antibodies and antibody fragments,based ... that it,has established a Scientific Advisory Board and ... of this advisory body. Members,of f-star,s Scientific Advisory ... College, London, UK, Sir Ravinder Maini is ...
... to six community organizations in ... underserved areas, WOODLAND HILLS, ... a total of $30,000 in end of,year donations to various food banks ... agencies in northern and,southern California to assist vulnerable populations., Blue Cross ...
Cached Medicine News:Health News:Society of Cardiovascular Magnetic Resonance chooses open access 2Health News:Anthem Blue Cross and Blue Shield Celebrates Local Moms-to-Be at Community Baby Shower 2Health News:Anthem Blue Cross and Blue Shield Celebrates Local Moms-to-Be at Community Baby Shower 3Health News:Obesity Weakens Immune Response 2Health News:Antibody Engineering Company f-star Appoints Three Pioneers in Antibody Engineering and Development to its Newly Established Scientific Advisory Board 2Health News:Antibody Engineering Company f-star Appoints Three Pioneers in Antibody Engineering and Development to its Newly Established Scientific Advisory Board 3Health News:Blue Cross of California Gives $30,000 in Holiday Donations to Food Banks Throughout the State 2
For use with Slitlamps which have a smaller distance between the eye and the reduction prism than the Haag-Streit 900. Designed to work with argon/YAG Lasers....
... complete image capture and management application that ... leading ophthalmic clinicians, ophthalmic photographers and optometrists ... securely document the eye via the slit ... slit lamps equipped with digital or video ...
... EyeCap SL is the most advanced means ... capture and management system that acquires extremely ... latest technology.Images can be captured directly from ... cameras, as well as any other ophthalmic ...
The best combination with the Haag-Streit 900 Slitlamps. For examination of the entire fundus, the vitreous and the iridocorneal angle. For children up to 4 years of age. 11 mm internal diameter of t...
Medicine Products: